Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 929033207 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
Amendment 3
|
9.9% |
8/14/2026
Event 6/30/2026
|
|
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | ||
| VHCP Co-Investment Holdings III, LLC | 9.9% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | ||
| VHCP Management III, LLC | 9.9% | ||
| VHCP Management EG, LLC | 9.9% | ||
| Nimish Shah | 9.9% | ||
| Bong Y. Koh | 9.9% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 1
|
4.2% |
8/14/2026
Event 6/30/2026
|
|
| Frazier Life Sciences Public Fund, L.P. | 4.2% | ||
| FHMLSP, L.P. | 4.2% | ||
| FHMLSP, L.L.C. | 4.2% | ||
| Frazier Life Sciences XI, L.P. | 0% | ||
| FHMLS XI, L.P. | 0% | ||
| FHMLS XI, L.L.C. | 0% | ||
| Frazier Life Sciences XII, L.P. | 0.5% | ||
| FHMLS XII, L.P. | 0.5% | ||
| FHMLS XII, L.L.C. | 0.5% | ||
| Verve Capital Ltd 13G/A Amendment 3 | 6.3% |
8/13/2026
Event 6/30/2026
|
|
|
FMR LLC
13G/A
Amendment 1
|
12.0% |
8/7/2026
Event 7/31/2026
|
|
| FMR LLC | 12.0% | ||
| Abigail P. Johnson | 12.0% | ||
|
FMR LLC
13G
|
9.1% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 9.1% | ||
| Abigail P. Johnson | 9.1% | ||
| BlackRock, Inc. 13G | 5.7% |
7/30/2026
Event 6/30/2026
|
|
|
RA Capital Management, L.P.
13D/A
Amendment 18
|
19.9% |
7/21/2026
Event 7/16/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
| Verve Capital Ltd 13G/A Amendment 2 | 9.3% |
5/15/2026
Event 3/31/2026
|
|
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
Amendment 2
|
9.9% |
5/15/2026
Event 3/31/2026
|
|
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | ||
| VHCP Co-Investment Holdings III, LLC | 9.9% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | ||
| VHCP Management III, LLC | 9.9% | ||
| VHCP Management EG, LLC | 9.9% | ||
| Nimish Shah | 9.9% | ||
| Bong Y. Koh | 9.9% | ||
|
Qiming Venture Partners VIII-HC, L.P.
13G/A
Amendment 2
|
2.0% |
5/6/2026
Event 3/31/2026
|
|
| Qiming Venture Partners VIII-HC, L.P. | 2.0% | ||
| Qiming Venture Partners VIII Investments, LLC | 1.7% | ||
| Qiming GP VIII, LLC | 1.7% | ||
| Qiming GP VIII-HC, LLC | 2.0% | ||
|
FMR LLC
13G/A
Amendment 2
|
3.2% |
5/6/2026
Event 3/31/2026
|
|
| FMR LLC | 3.2% | ||
| Abigail P. Johnson | 3.2% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 17
|
19.9% |
4/21/2026
Event 4/20/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 16
|
19.9% |
4/15/2026
Event 4/14/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 15
|
19.9% |
4/10/2026
Event 4/9/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 14
|
19.9% |
4/8/2026
Event 4/6/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 13
|
19.9% |
4/1/2026
Event 3/30/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
|
TCG Crossover GP II, LLC
13G
|
10.5% |
4/1/2026
Event 3/30/2026
|
|
| TCG Crossover GP II, LLC | 5.2% | ||
| TCG Crossover Fund II, L.P. | 5.2% | ||
| TCG Crossover GP III, LLC | 5.2% | ||
| TCG Crossover Fund III, L.P. | 5.2% | ||
| Chen Yu | 10.5% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 12
|
19.9% |
3/16/2026
Event 3/12/2026
|
|
| RA Capital Management, L.P. | 19.9% | ||
| Peter Kolchinsky | 19.9% | ||
| Rajeev Shah | 19.9% | ||
| RA Capital Healthcare Fund, L.P. | 19.9% | ||
| Verve Capital Ltd 13G/A Amendment 1 | 9.9% |
2/17/2026
Event 12/31/2025
|
|
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
Amendment 1
|
9.9% |
2/17/2026
Event 12/31/2025
|
|
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | ||
| VHCP Co-Investment Holdings III, LLC | 9.9% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | ||
| VHCP Management III, LLC | 9.9% | ||
| VHCP Management EG, LLC | 9.9% | ||
| Nimish Shah | 9.9% | ||
| Bong Y. Koh | 9.9% | ||
|
Great Point Partners, LLC
13G/A
Amendment 1
|
3.3% |
2/17/2026
Event 12/31/2025
|
|
| Great Point Partners, LLC | 3.3% | ||
| Dr. Jeffrey R. Jay, M.D. | 3.3% | ||
| Ms. Lillian Nordahl | 3.3% | ||
|
Paradigm Biocapital Advisors LP
13G/A
Amendment 1
|
4.5% |
2/17/2026
Event 12/31/2025
|
|
| Paradigm BioCapital Advisors LP | 4.5% | ||
| Paradigm BioCapital Advisors GP LLC | 4.5% | ||
| Senai Asefaw, M.D. | 4.5% | ||
| Paradigm BioCapital International Fund Ltd. | 4.0% | ||
|
Qiming Venture Partners VIII-HC, L.P.
13G/A
Amendment 1
|
2.8% |
2/13/2026
Event 12/31/2025
|
|
| Qiming Venture Partners VIII-HC, L.P. | 2.8% | ||
| Qiming Venture Partners VIII Investments, LLC | 2.4% | ||
| Qiming GP VIII, LLC | 2.4% | ||
| Qiming GP VIII-HC, LLC | 2.8% | ||
|
FMR LLC
13G/A
Amendment 1
|
6.5% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 6.5% | ||
| Abigail P. Johnson | 6.5% | ||
|
ForGrowth III PA B.V.
13D
|
10.0% |
12/23/2025
Event 12/18/2025
|
|
| ForGrowth III PA B.V. | 10.0% | ||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10.0% | ||
| Forbion Growth III Management B.V. | 10.0% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G
|
5.8% |
12/19/2025
Event 12/18/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 5.8% | ||
| FHMLSP, L.P. | 5.8% | ||
| FHMLSP, L.L.C. | 5.8% | ||
| Frazier Life Sciences XI, L.P. | 0.1% | ||
| FHMLS XI, L.P. | 0.1% | ||
| FHMLS XI, L.L.C. | 0.1% | ||
| Frazier Life Sciences XII, L.P. | 0.7% | ||
| FHMLS XII, L.P. | 0.7% | ||
| FHMLS XII, L.L.C. | 0.7% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 11
|
14.0% |
12/18/2025
Event 12/18/2025
|
|
| RA Capital Management, L.P. | 14.0% | ||
| Peter Kolchinsky | 14.0% | ||
| Rajeev Shah | 14.0% | ||
| RA Capital Healthcare Fund, L.P. | 14.0% | ||
|
Great Point Partners, LLC
13G
|
5.6% |
12/17/2025
Event 12/10/2025
|
|
| Great Point Partners, LLC | 5.6% | ||
| Dr. Jeffrey R. Jay, M.D. | 5.6% | ||
| Ms. Lillian Nordahl | 5.6% | ||
|
Paradigm Biocapital Advisors LP
13G
|
8.6% |
11/18/2025
Event 11/11/2025
|
|
| Paradigm BioCapital Advisors LP | 8.6% | ||
| Paradigm BioCapital Advisors GP LLC | 8.6% | ||
| Senai Asefaw, M.D. | 8.6% | ||
| Paradigm BioCapital International Fund Ltd. | 7.6% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 10
|
9.9% |
11/14/2025
Event 11/12/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
FMR LLC
13G
|
11.5% |
11/7/2025
Event 10/31/2025
|
|
| FMR LLC | 11.5% | ||
| Abigail P. Johnson | 11.5% | ||
|
Qiming Venture Partners VIII-HC, L.P.
13G
|
5.4% |
11/5/2025
Event 9/18/2025
|
|
| Qiming Venture Partners VIII Investments, LLC | 4.6% | ||
| Qiming Venture Partners VIII-HC, L.P. | 5.4% | ||
| Qiming GP VIII, LLC | 4.6% | ||
| Qiming GP VIII-HC, LLC | 5.4% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 9
|
11.5% |
10/30/2025
Event 10/28/2025
|
|
| RA Capital Management, L.P. | 11.5% | ||
| Peter Kolchinsky | 11.5% | ||
| Rajeev Shah | 11.5% | ||
| RA Capital Healthcare Fund, L.P. | 11.4% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 8
|
17.3% |
10/27/2025
Event 10/23/2025
|
|
| RA Capital Management, L.P. | 17.3% | ||
| Peter Kolchinsky | 17.3% | ||
| Rajeev Shah | 17.3% | ||
| RA Capital Healthcare Fund, L.P. | 17.2% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 7
|
20.9% |
10/20/2025
Event 10/16/2025
|
|
| RA Capital Management, L.P. | 20.9% | ||
| Peter Kolchinsky | 20.9% | ||
| Rajeev Shah | 20.9% | ||
| RA Capital Healthcare Fund, L.P. | 20.8% | ||
|
Reprogrammed Interchange LLC
13D/A
Amendment 8
|
17.6% |
10/17/2025
Event 10/15/2025
|
|
| Reprogrammed Interchange LLC | 17.6% | ||
| Reid Hoffman | 17.6% | ||
| Verve Capital Ltd 13G | 9.9% |
9/26/2025
Event 9/18/2025
|
|
|
Venrock Healthcare Capital Partners III, L.P.
13G
|
9.9% |
9/25/2025
Event 9/18/2025
|
|
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | ||
| VHCP Co-Investment Holdings III, LLC | 9.9% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | ||
| VHCP Management III, LLC | 9.9% | ||
| VHCP Management EG, LLC | 9.9% | ||
| Nimish Shah | 9.9% | ||
| Bong Y. Koh | 9.9% | ||
|
ForGrowth III PA B.V.
13G
|
10.0% |
9/23/2025
Event 9/18/2025
|
|
| ForGrowth III PA B.V. | 10.0% | ||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10.0% | ||
| Forbion Growth III Management B.V. | 10.0% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 6
|
29.0% |
9/19/2025
Event 9/17/2025
|
|
| RA Capital Management, L.P. | 29.0% | ||
| Peter Kolchinsky | 29.0% | ||
| Rajeev Shah | 29.0% | ||
| RA Capital Healthcare Fund, L.P. | 27.6% |